Patient guide · Reviewed June 2026
Finding a Bariatric Surgeon as a GLP-1 Patient in Australia
GLP-1 medications have transformed weight management in Australia. But there are specific situations where seeing a bariatric surgeon is the right next step — whether you are plateauing on medication, considering surgery as an alternative, or managing your weight after a previous procedure.
This guide explains when a bariatric surgeon is appropriate for GLP-1 patients, what the consultation involves, and how to find one in Australia.
Published 2026-06-01 · Clinically reviewed 2026-06-03
Patient guide · Reviewed June 2026
The Changing Relationship Between GLP-1 Medications and Bariatric Surgery
GLP-1 medications and bariatric surgery are no longer competing alternatives. Increasingly, they are complementary tools in a spectrum of obesity management…
GLP-1 medications and bariatric surgery are no longer competing alternatives. Increasingly, they are complementary tools in a spectrum of obesity management options.
The Australian healthcare system is developing models of care where patients move between medication and surgery depending on their response, preference, and clinical situation. When and how to recommend weight loss surgery is now explicitly addressed in Australian obesity management guidance alongside GLP-1 therapy — the approach is multidisciplinary and patient-specific, not binary.
Metabolic bariatric surgery utilisation decreased by 34% globally from 2022 to 2025, while GLP-1 prescriptions increased by 140% in the same period. The Australian decline was partially masked by supply shortages of GLP-1 medications in 2023–24, but has since accelerated as supply normalised. This has not made bariatric surgeons irrelevant — it has changed the patient population they see and the questions they address.
When Should a GLP-1 Patient See a Bariatric Surgeon?
1. You have plateaued on GLP-1 medication despite full titration
A GLP-1 plateau that persists beyond 8–12 weeks at maximum dose, despite dietary optimisation and resistance training, may indicate that pharmacological therapy alone is insufficient. For patients with starting BMI above 40–45, bariatric surgery can produce weight loss outcomes that exceed what GLP-1 medications achieve on average — and can be complemented by GLP-1 therapy post-operatively for long-term maintenance.
2. You have insufficient weight loss at maximum GLP-1 dose
Clinical trials show average weight loss of 14–22% with GLP-1 medications. Some patients lose substantially more; some lose substantially less. If after 12 months at maximum dose your weight loss is below 5–7%, surgery may produce significantly better outcomes. A bariatric surgeon can assess eligibility and advise.
3. You have experienced weight regain after previous bariatric surgery
Post-bariatric weight regain affects approximately 20–30% of patients within 2–5 years. A bariatric surgeon can review your surgical history, assess anatomical changes, and advise whether revision surgery, pharmacological management, or a combination is most appropriate.
4. You are considering bariatric surgery alongside GLP-1 therapy
Some patients use GLP-1 medications as a bridge to bariatric surgery — to reduce pre-operative weight and risk. A bariatric surgeon and GP work together to plan the optimal timing and transition between medication and surgery.
5. Post-bariatric monitoring and follow-up
If you had bariatric surgery years ago and have lost contact with your surgical team, re-establishing that relationship is clinically important — particularly if you are starting GLP-1 therapy post-operatively. Your surgeon has knowledge of your specific anatomy that is relevant to prescribing and monitoring decisions.
Patient guide · Reviewed June 2026
What a Bariatric Surgery Consultation Involves
A first consultation with a bariatric surgeon for GLP-1 patients typically includes:
A first consultation with a bariatric surgeon for GLP-1 patients typically includes:
Medical history review: Surgical history (if any), weight history, current medications including GLP-1 details, comorbidities, response to current treatment.
Anthropometric assessment: BMI, waist circumference, body composition.
Relevant investigations: Blood panel, liver function and FIB-4 calculation, imaging (abdominal ultrasound, sometimes CT for anatomy assessment), cardiac risk assessment if indicated.
Discussion of options: The surgeon will discuss all available options — continuation of GLP-1 therapy, revision of previous surgery (if applicable), primary surgery (if no previous procedure), or combination approaches.
Realistic expectations: Modern bariatric surgeons are clear about what surgery can and cannot achieve, particularly in the GLP-1 era. A good consultation sets realistic expectations for weight loss, timeline, recovery, and long-term management requirements.
Multidisciplinary referrals: Most accredited bariatric programmes include mandatory referrals to a dietitian and psychologist before surgery. These assessments are clinically required, not optional.
The Liver Assessment Before Bariatric Surgery or GLP-1 Therapy
Before bariatric surgery, liver assessment is standard in Australian centres. Surgeons need to know liver size, fat content, and fibrosis status — both for surgical planning (an enlarged fatty liver complicates laparoscopic access) and because MASH is increasingly an independent indication for specific treatments.
The MJA September 2025 consensus statement recommends FIB-4 → elastography assessment for all patients with obesity or metabolic risk factors. All bariatric surgery patients and all GLP-1 patients meet this criteria. If you have not had a liver assessment, discuss this with your surgeon and GP.
Find a liver elastography clinic near you →
What Australian guidelines say about GLP-1 and liver health →
Patient guide · Reviewed June 2026
How to Access a Bariatric Surgeon in Australia
GP referral pathway: Your GP can provide a referral to a bariatric surgeon. Request a referral specifically to a surgeon with experience in post-bariatric…
GP referral pathway: Your GP can provide a referral to a bariatric surgeon. Request a referral specifically to a surgeon with experience in post-bariatric GLP-1 management if that is your situation.
Private vs public: Bariatric surgery in Australia is available through both the public and private systems. Public waiting lists are typically long — 1–3 years in most states. Private surgeons have shorter waiting times but surgery costs $15,000–$25,000 out of pocket depending on procedure and hospital.
Private health insurance: Most hospital-level private health insurance covers bariatric surgery after a 12-month waiting period for weight-related procedures. Check your specific policy for bariatric surgery coverage before consultation.
Self-referral: Some bariatric surgeons in Australia accept self-referrals for an initial consultation. You can contact their rooms directly, though bringing a GP referral letter is recommended.
Find a liver elastography clinic near you
Search by suburb or postcode to see accredited clinics offering FibroScan and guided liver elastography across Australia.
Type a suburb or postcode and press Enter to search nearby.
Request a liver scan appointment
Submit your details and we'll route your request to the most appropriate elastography clinic in your area. Most clinics respond within 1–2 business days.
Take action
Request an appointment
Frequently asked questions
Do I need a GP referral to see a bariatric surgeon in Australia?
Technically some surgeons accept direct bookings. However, a GP referral is strongly recommended — it provides context, ensures your medical history is communicated, and may attract a Medicare rebate for the initial consultation. For post-bariatric GLP-1 patients, the GP referral should include your surgical history and current GLP-1 dose.
Can a bariatric surgeon prescribe GLP-1 medications?
Bariatric surgeons are typically not the primary prescribers of GLP-1 medications — that role belongs to GPs and endocrinologists. However, a bariatric surgeon will advise on the appropriateness of GLP-1 therapy relative to surgical options and will coordinate with your GP on prescribing decisions.
What is the difference between a bariatric surgeon and a metabolic surgeon?
These terms are largely interchangeable in Australian practice. Metabolic surgery emphasises the metabolic benefits (diabetes remission, cardiovascular risk reduction) alongside weight loss. Both terms refer to surgical procedures including sleeve gastrectomy, gastric bypass (Roux-en-Y), and related procedures.
How long does the bariatric surgery pathway take in Australia?
From initial GP referral to surgery in the private system: typically 3–6 months including assessments, dietitian and psychology consultations, and pre-operative preparation. In the public system, waiting lists are 1–3 years in most states.
If I have been on GLP-1 for years, can I still have bariatric surgery?
Yes. Prior GLP-1 use does not preclude bariatric surgery. Surgeons will typically ask you to stop GLP-1 medications 7–14 days before surgery (due to gastroparesis risk and anaesthetic safety). Discuss timing with your surgeon.
Sources: MJA GLP-1 obesity CVD treatment guide insightplus June 2026; MJA role of GLP-1 receptor agonists obesity February 2025; JAMA Surgery bariatric surgery decline May 2026; MedCentral GLP-1s post-bariatric March 2026; MJA MAFLD consensus statement September 2025.
This article is for educational purposes only. It does not constitute medical advice. Always consult your GP or a specialist about your individual health circumstances.
Next step
Find a liver elastography clinic near you
Search participating clinics across Australia, or talk to your GP about a baseline FIB-4 and elastography.